Quanta Inc (fka QNTA)

[~MulaGreen~]

This creates an opportunity for Medolife to demonstrate Escozine’s effectiveness in the country as a therapeutic and palliative medicine,” said Medolife CEO Dr. Arthur Mikaelian.
"Through our study on Escozine®, we were able to show that it diminishes some of the side-effects of vaccines".
This creates more confidence by the general population and further aids governments in implementation of vaccine programs.
Beyond the opportunity for us to help the population of the DR, an approval of this kind will open the door to further negotiations for distribution in other Latin American countries.
Overall, the outcome of the meeting was very positive, and we look forward to working closer with the Vice President and government of the DR.”